Literature DB >> 27500791

Highlights From the American Association of Pharmaceutical Scientists/ International Transporter Consortium Joint Workshop on Drug Transporters in Absorption, Distribution, Metabolism, and Excretion: From the Bench to the Bedside - Clinical Pharmacology Considerations.

P T Ronaldson1, B Bauer2, A F El-Kattan3, H Shen4, L Salphati5, S W Louie6.   

Abstract

The American Association of Pharmaceutical Scientists/International Transporter Consortium Joint Workshop on Drug Transporters in absorption, distribution, metabolism, and excretion was held with the objective of discussing innovative advances in transporter pharmacology. Specific topics included (i) transporters at the blood-brain barrier (BBB); (ii) emerging transport proteins; (iii) recent advances in achieving hepatoselectivity and optimizing clearance for organic anion-transporting polypeptide (OATP) substrates; (iv) utility of animal models for transporter studies; and (v) clinical correlation of transporter polymorphisms. Here, we present state-of-the-art highlights from this workshop in these key areas of focus.
© 2016 ASCPT.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27500791      PMCID: PMC5466066          DOI: 10.1002/cpt.439

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  10 in total

1.  Identification of P-glycoprotein co-fractionating proteins and specific binding partners in rat brain microvessels.

Authors:  Margaret E Tome; Charles P Schaefer; Leigh M Jacobs; Yifeng Zhang; Joseph M Herndon; Fabian O Matty; Thomas P Davis
Journal:  J Neurochem       Date:  2015-04-21       Impact factor: 5.372

2.  Evaluation of organic anion transporting polypeptide 1B1 and 1B3 humanized mice as a translational model to study the pharmacokinetics of statins.

Authors:  Laurent Salphati; Xiaoyan Chu; Liangfu Chen; Bhagwat Prasad; Shannon Dallas; Raymond Evers; Donna Mamaril-Fishman; Ethan G Geier; Jonathan Kehler; Jeevan Kunta; Mario Mezler; Loic Laplanche; Jodie Pang; Anja Rode; Matthew G Soars; Jashvant D Unadkat; Robert A B van Waterschoot; Jocelyn Yabut; Alfred H Schinkel; Nico Scheer
Journal:  Drug Metab Dispos       Date:  2014-05-22       Impact factor: 3.922

3.  A "middle-out" approach to human pharmacokinetic predictions for OATP substrates using physiologically-based pharmacokinetic modeling.

Authors:  Rui Li; Hugh A Barton; Phillip D Yates; Avijit Ghosh; Angela C Wolford; Keith A Riccardi; Tristan S Maurer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-04-10       Impact factor: 2.745

4.  Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior.

Authors:  Carole Saison; Virginie Helias; Bryan A Ballif; Thierry Peyrard; Hervé Puy; Toru Miyazaki; Sébastien Perrot; Muriel Vayssier-Taussat; Mauro Waldner; Pierre-Yves Le Pennec; Jean-Pierre Cartron; Lionel Arnaud
Journal:  Nat Genet       Date:  2012-01-15       Impact factor: 38.330

5.  Evaluation of rosuvastatin as an organic anion transporting polypeptide (OATP) probe substrate: in vitro transport and in vivo disposition in cynomolgus monkeys.

Authors:  Hong Shen; Hong Su; Tongtong Liu; Ming Yao; Gabe Mintier; Lun Li; R Marcus Fancher; Ramaswamy Iyer; Punit Marathe; Yurong Lai; A David Rodrigues
Journal:  J Pharmacol Exp Ther       Date:  2015-03-04       Impact factor: 4.030

Review 6.  Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injury.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Brain Res       Date:  2015-03-18       Impact factor: 3.252

Review 7.  Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake.

Authors:  Mikko Niemi; Marja K Pasanen; Pertti J Neuvonen
Journal:  Pharmacol Rev       Date:  2011-01-18       Impact factor: 25.468

8.  Evaluation of Oatp and Mrp2 activities in hepatobiliary excretion using newly developed positron emission tomography tracer [11C]dehydropravastatin in rats.

Authors:  Tomotaka Shingaki; Tadayuki Takashima; Ryosuke Ijuin; Xuan Zhang; Tomohiro Onoue; Yumiko Katayama; Takashi Okauchi; Emi Hayashinaka; Yilong Cui; Yasuhiro Wada; Masaaki Suzuki; Kazuya Maeda; Hiroyuki Kusuhara; Yuichi Sugiyama; Yasuyoshi Watanabe
Journal:  J Pharmacol Exp Ther       Date:  2013-08-07       Impact factor: 4.030

9.  Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain.

Authors:  Ronald E Cannon; John C Peart; Brian T Hawkins; Christopher R Campos; David S Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

10.  Application of a Physiologically Based Pharmacokinetic Model to Predict OATP1B1-Related Variability in Pharmacodynamics of Rosuvastatin.

Authors:  R H Rose; S Neuhoff; K Abduljalil; M Chetty; A Rostami-Hodjegan; M Jamei
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-07-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.